Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00177268 · ClinicalTrials.gov registry record
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
A clinical trial of Atopic Dermatitis and Eczema, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT00177268: Recruiting study of Atopic Dermatitis and Eczema, sponsored by University of Pittsburgh.
NCT00177268 is a study of Atopic Dermatitis and Eczema that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 200 participants, below the 608-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00177268, a study of Atopic Dermatitis and Eczema, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.
Primary Outcome
Proteomic variables will be measured in blood and tissue of consented CTCL patients.
Conditions Studied
Interventions
- OTHER Blood draw, skin biopsy or urine collection
Study Locations (1)
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2004-10 |
| Est. Completion | 2032-01 |
What NCT00177268 shows while recruiting
NCT00177268 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 608-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (67% lower).
The record links to 5 conditions, with Atopic Dermatitis appearing as the primary indexed condition, and to 1 intervention - of which Blood draw, skin biopsy or urine collection is the first listed.
NCT00177268 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00177268 about?
NCT00177268 is a clinical study titled "Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research". This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.
What is the current status of trial NCT00177268?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2004-10. Estimated completion is 2032-01.
What conditions does trial NCT00177268 study?
This clinical trial studies the following conditions: Atopic Dermatitis, Eczema, Cutaneous T Cell Lymphoma, Mycosis Fungoides, Sezary Syndrome.
What interventions are being tested in trial NCT00177268?
The interventions under investigation include: Blood draw, skin biopsy or urine collection (OTHER).
Who is sponsoring clinical trial NCT00177268?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00177268 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atopic Dermatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00177268's enrollment target sits among peer trials
200 56th of 150 higher than 89 of 150 other Atopic Dermatitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atopic Dermatitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry for Systemic Eczema Treatments
RECRUITING
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
RECRUITING
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
-
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RECRUITING · Phase 2
-
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
RECRUITING · Phase 1
-
Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
- NCT00568490 · 200 participants
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia